"mRNA is expected to become one of the major pillars of drug development. With an increasing number of concepts entering clinical trials, the first approval of an mRNA therapeutic against cancer is nearing" are the concluding lines of a review paper published in April 2021 molecular-cancer.biomedcent... Now that therapeutic is a step closer: Moderna, Merck & Co. mRNA cancer vaccine slashes melanoma recurrence in Keytruda combo trial fiercebiotech.com/biotech/m...
THE WEBINAR: Delivery of mRNA Therapies: Bob Langer Discusses Past, Present, and Future
Drug delivery technologies, including microparticles, nanoparticles, and nanotechnology, promise to create new treatments for cancer, heart disease, and other illnesses. Nanotechnology has proven effective for therapeutic DNA and RNA delivery, including the rapid development of nanoparticles for the COVID-19 mRNA vaccine and in vivo delivery of CRISPR gene editing therapy.
WHEN: Friday, December 16, 2022, 8:00 am PT, 11:00 am ET, 17:00 CET
REGISTER FREE: gen.omeclk.com/portal/publi...